Genetic Technologies Ltd (GTG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Genetic Technologies Ltd (GTG) has a cash flow conversion efficiency ratio of 0.067x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-144.47K ≈ $-102.22K USD) by net assets (AU$-2.17 Million ≈ $-1.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See GTG equity financing ratio to measure how much of total assets are equity-financed.
Genetic Technologies Ltd - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Genetic Technologies Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Genetic Technologies Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Genetic Technologies Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genetic Technologies Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Octopus Renewables Infra Trust
LSE:ORIT
|
0.039x |
|
Parx Plastics NV
PA:MLPRX
|
N/A |
|
Harvest Gold Corp
V:HVG
|
-0.035x |
|
Hubify Ltd
AU:HFY
|
0.055x |
|
Dlaboratory Sweden AB
ST:DLAB
|
0.162x |
|
Entreprendre
PA:ALENR
|
0.003x |
|
DMD Digital Health Connections Group Inc
NASDAQ:APTOF
|
0.215x |
|
Ashtead Technology Holdings PLC
LSE:AT
|
0.153x |
Annual Cash Flow Conversion Efficiency for Genetic Technologies Ltd (2000–2024)
The table below shows the annual cash flow conversion efficiency of Genetic Technologies Ltd from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see GTG company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-06-30 | AU$1.83 Million ≈ $1.30 Million |
AU$-9.68 Million ≈ $-6.85 Million |
-5.288x | -507.08% |
| 2023-06-30 | AU$11.16 Million ≈ $7.90 Million |
AU$-9.72 Million ≈ $-6.88 Million |
-0.871x | -152.89% |
| 2022-06-30 | AU$16.43 Million ≈ $11.63 Million |
AU$-5.66 Million ≈ $-4.00 Million |
-0.344x | -17.80% |
| 2021-06-30 | AU$21.53 Million ≈ $15.24 Million |
AU$-6.30 Million ≈ $-4.45 Million |
-0.292x | +28.38% |
| 2020-06-30 | AU$13.99 Million ≈ $9.90 Million |
AU$-5.71 Million ≈ $-4.04 Million |
-0.408x | +88.09% |
| 2019-06-30 | AU$1.77 Million ≈ $1.25 Million |
AU$-6.07 Million ≈ $-4.30 Million |
-3.429x | -186.63% |
| 2018-06-30 | AU$4.71 Million ≈ $3.33 Million |
AU$-5.64 Million ≈ $-3.99 Million |
-1.196x | -85.73% |
| 2017-06-30 | AU$10.58 Million ≈ $7.49 Million |
AU$-6.81 Million ≈ $-4.82 Million |
-0.644x | +0.95% |
| 2016-06-30 | AU$11.88 Million ≈ $8.41 Million |
AU$-7.73 Million ≈ $-5.47 Million |
-0.650x | -27.20% |
| 2015-06-30 | AU$18.96 Million ≈ $13.41 Million |
AU$-9.69 Million ≈ $-6.86 Million |
-0.511x | +91.50% |
| 2014-06-30 | AU$1.83 Million ≈ $1.29 Million |
AU$-10.99 Million ≈ $-7.77 Million |
-6.012x | -360.56% |
| 2013-06-30 | AU$5.76 Million ≈ $4.07 Million |
AU$-7.52 Million ≈ $-5.32 Million |
-1.305x | -144.99% |
| 2012-06-30 | AU$14.40 Million ≈ $10.19 Million |
AU$-7.67 Million ≈ $-5.43 Million |
-0.533x | -262.57% |
| 2011-06-30 | AU$6.81 Million ≈ $4.82 Million |
AU$2.23 Million ≈ $1.58 Million |
0.328x | +143.55% |
| 2010-06-30 | AU$5.72 Million ≈ $4.05 Million |
AU$-4.30 Million ≈ $-3.04 Million |
-0.753x | -115.70% |
| 2009-06-30 | AU$17.49 Million ≈ $12.37 Million |
AU$-6.10 Million ≈ $-4.32 Million |
-0.349x | -1815.27% |
| 2008-06-30 | AU$20.83 Million ≈ $14.74 Million |
AU$423.68K ≈ $299.78K |
0.020x | -84.38% |
| 2007-06-30 | AU$16.90 Million ≈ $11.96 Million |
AU$2.20 Million ≈ $1.56 Million |
0.130x | +138.82% |
| 2006-06-30 | AU$18.27 Million ≈ $12.92 Million |
AU$-6.13 Million ≈ $-4.33 Million |
-0.335x | -15.98% |
| 2005-06-30 | AU$22.75 Million ≈ $16.10 Million |
AU$-6.58 Million ≈ $-4.65 Million |
-0.289x | -9.13% |
| 2004-06-30 | AU$17.07 Million ≈ $12.08 Million |
AU$-4.52 Million ≈ $-3.20 Million |
-0.265x | -627.25% |
| 2003-06-30 | AU$27.28 Million ≈ $19.30 Million |
AU$-993.71K ≈ $-703.11K |
-0.036x | +65.80% |
| 2002-06-30 | AU$31.14 Million ≈ $22.03 Million |
AU$-3.32 Million ≈ $-2.35 Million |
-0.107x | -81.95% |
| 2001-06-30 | AU$38.07 Million ≈ $26.94 Million |
AU$-2.23 Million ≈ $-1.58 Million |
-0.059x | -39.21% |
| 2000-06-30 | AU$7.58 Million ≈ $5.36 Million |
AU$-318.68K ≈ $-225.49K |
-0.042x | -- |
About Genetic Technologies Ltd
Genetic Technologies Limited, a molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people's health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company operates through EasyDNA, AffinityDNA, and GeneType/Corporate segments. It offers BREVAGenplus, a clinicall… Read more